" "

As of Wednesday, March 18, HCA’s lobby will be closed. In-person customer services for Apple Health and the PEBB and SEBB Programs will not be available. Learn more.

Prescription drug cost transparency

Want to stay up-to-date on prescription drug cost transparency?

Sign up for notifications


In 2019, the Washington State Legislature passed Engrossed Second Substitute House Bill into law. This law states requires issuers of health insurance, pharmacy benefit managers (PBMs), manufacturers, and pharmacy service administrative organizations (PSAOs) to submit data to the Health Care Authority (HCA). The purpose is to create an annual report on how prescription drugs affect health care costs. The law also requires pharmaceutical manufacturers to submit data to HCA relating the new drug applications (NDA).


HCA is currently in the planning phase of this effort. It is estimated that it will take up to 12 months to complete the rule making process. We will have information specific to each information supplier at a future date.

Drug manufacturers, health carriers, pharmacy benefit managers (PBMs), and pharmacy services administrative organizations (PSAOs) are not expected to submit data in 2019. There will not be imposed fines for not submitting in 2019. HCA anticipates being ready to collect data by October 2020.

Stakeholder meetings

At each meeting, HCA will give a short overview of Chapter 43.71C RCW then use the majority of time to take questions and hear concerns from stakeholders. We will focus on a different supplier in each meeting. The public is invited to participate in any of the meetings.

All meetings will be held at:

The Health Care Authority
626 8th Ave SE, Olympia, WA, 98501
Sue Crystal, room 106

Check in at the front desk to get a visitor badge.

If you cannot attend the meetings but would like to ask questions or make a comment, please send them to drugtransparency@hca.wa.gov at least seven business days before the corresponding meeting date. Your testimony will be read at the meeting. There is a separate GoTo Webinar link for each meeting, you can ask questions in the chat function during the meeting.

Meeting schedule

After registering, you will receive a confirmation email with information on how to join the webinar.

Date and time Meeting type Registration Materials
February 26, 2020
2:30-4 p.m.
Manufacturer reporting Closed

Slide deck (02/26/20)

Recorded webinar (02/26/20)

April 1, 2020
1-2:30 p.m.

Issuer / carrier reporting

Webinar only, no in person meeting due to COVID-19

Register (04/01/20) ​  Updated slide deck (04/01/20)
April 29, 2020
2:30-4 p.m.
Pharmacy benefit manager / pharmacy service administrative organization reporting Register (04/29/20)